442
Participants
Start Date
March 21, 2023
Primary Completion Date
January 4, 2024
Study Completion Date
December 9, 2024
Placebo
We will evaluate how many women gets an infection and/or wound dehiscence after a second degree obstetric tear or episiotomy
Bioclavid (Amoxicillin and Clavulanic acid)
We will evaluate how many women gets an infection and/or wound dehiscence after a second degree obstetric tear or episiotomy
Maternaty ward, Herlev Hospital, Herlev
Region Hovedstadens Apotek
OTHER_GOV
Hanna Jangö
OTHER